HLNHaleon plc

NYSE


$ 10.56 $ -0.10 (-0.94 %)    

Wednesday, 18-Sep-2024 15:59:00 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 10.55
$ 10.74
$ 10.55 x 2,800
$ 10.56 x 5,700
$ 10.52 - $ 10.75
$ 7.47 - $ 10.76
6,551,434
na
97.42B
$ 0.27
$ 72.88
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

PubMatic (NASDAQ:PUBM), an independent technology company delivering digital advertising's supply chain of the future, toda...

 haleon-launches-eroxon-in-us-preorder-without-a-prescription

Eroxon® is Haleon's first offering in the sexual health space Clinical studies show Eroxon® is safe and effective in men wi...

 haleon-reiterated-fy24-organic-revenue-growth-of-4-6

Updating guidance for FY2024 and confident of delivery on medium term guidance  ● Organic revenue growth expected to be 4-6% ● ...

 haleon-to-offload-non-core-nicotine-therapy-business-to-dr-reddys-for-over-600m

Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories SA for £50...

Core News & Articles

Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol an...

 sanofi-looks-to-sell-20b-icy-hot-division-likely-bidders-include-advent-pai-partners-blackstone-cvc

Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.

 gsk-completely-exits-sensodyne-toothpaste-maker-haleon-in-16b-sale

GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advi...

Core News & Articles

GSK plc (LSE/NYSE: GSK) today announced that it intends to sell approximately 385m ordinary shares in Haleon, equivalent to app...

 haleon-appoints-dawn-allen-as-cfo-after-tobias-hestler-announced-to-step-down-dawn-will-join-haleon-on-28-october-and-will-assume-the-role-of-cfo-from-1-november

https://www.haleon.com/news/press-releases/corporate/2024/appointment-of-dawn-allen-as-chief-financial-officer

 argus-research-maintains-buy-on-haleon-maintains-10-price-target

Argus Research analyst Taylor Conrad maintains Haleon (NYSE:HLN) with a Buy and maintains $10 price target.

 pfizer-to-cut-stake-in-sensodyne-toothpaste-maker-haleon-potentially-worth-2b

Pfizer to reduce stake in Haleon to approximately 24% following earlier divestment announcement. Offer price per share to be re...

 advil-maker-haleon-expects-higher-2024-revenue-after-strong-2023-earnings-stock-soars

Haleon reports FY 2023 revenue growth of 4.1% to £11.3 billion ($14.03 billion), missing consensus. Adjusted operating profit r...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

 haleon-fy-sales-1403b-miss-1447b-estimate

Haleon (NYSE:HLN) reported quarterly sales of $14.03 billion which missed the analyst consensus estimate of $14.47 billion by 3...

 haleon-earnings-preview
Haleon Earnings Preview
02/28/2024 14:01:16

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION